Skip to main content

Table 1 Clinical and CMR characteristics of patients with and without "physiologic basal septal LGE".

From: Differentiation of physiologic versus pathologic basal septal fibrosis: Proposed diagnostic criteria and associations with clinical and CMR-based markers of cardiovascular disease

  "Physiologic basal basal LGE" p-value
Clinical variables Present (n = 73) Absent (n = 357)  
Age (years) 59.2 ± 12.7 55.1 ± 14.9 0.030
Male (n, %) 51 (69.9) 230 (64.4) 0.374
BMI (g/m2) 29.0 ± 5.1 28.2 ± 5.5 0.215
GFR (mL/min) 82.3 ± 22.1 77.4 ± 22.1 0.098
Smoking (n, %) 19 (26.0) 105 (29.4) 0.561
Hyperlipedemia (n, %) 29 (39.7) 140 (39.2) 0.935
Diabetes (n, %) 10 (13.7) 61 (17.1) 0.477
Hypertension (n, %) 32 (43.8) 139 (38.9) 0.436
History of coronary disease (n, %) 20 (27.4) 129 (36.1) 0.153
NYHA class    
Class I - II (n, %) 23 (63.9) 140 (61.9)  
Class III - IV (n, %) 13 (36.1) 86 (38.1) 0.823
CMR variables    
- LV anteroseptal wall thickness (mm) 10.8 ± 3.5 10.8 ± 4.1 0.963
- LV end diastolic volume index (mL/m2) 86.2 ± 40.4 97.0 ± 43.2 0.051
- LV mass index (mL/m2) 81.3 ± 27.6 86.2 ± 28.8 0.185
- LV ejection fraction (%) 53.8 ± 19.4 48.1 ± 22.2 0.045
- RV end diastolic volume index (mL/m2) 63.2 ± 18.2 65.8 ± 24.5 0.374
- RV ejection fraction (%) 57.7 ± 13.0 54.0 ± 15.5 0.061
- Presence of LGE (n, %) 41 (56.2) 243 (68.1) 0.050
- Total fibrosis (≥ 5 SD threshold) (mL) 10.6 ± 14.9 12.4 ± 17.9 0.440
- Percentage of fibrosis (≥ 5 SD threshold) (%) 9.8 ± 12.9 11.1 ± 14.5 0.44
  1. Data are means ± standard deviation. BMI = body mass index. LV = left ventricle. RV = right ventricle. LGE = Late gadolinium enhancement.